Skip to content

Clinical trials

Completed Neoplasms, Glandular and Epithelial trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms, Glandular and Epithelial Status: Completed Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20142
20151
20165
20171
20181
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma America, Inc.3
Syndax Pharmaceuticals2
Advaxis, Inc.1
Boston Scientific Corporation1
DNAtrix, Inc.1
Dendreon1
Genelux Corporation1
Hoffmann-La Roche1
Imunon1
Neovii Biotech1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms, Glandular and Epithelial17
Neoplasms14
Digestive System Neoplasms11
Neoplasms by Histologic Type11
Adenocarcinoma9
Digestive System Diseases9
Neoplasms by Site9
Carcinoma8
Endocrine Gland Neoplasms6
Bronchial Neoplasms4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.